Methods We searched in four databases (PubMed, Embase, Cochrane Library, and Web of Science) from inception to 1 November 2022 (updated on March 20, 2023) for potentially relevant records without language restrictions
Examples include liraglutide (LEAN Project: ClinicalTrials.gov, number NCT01237119) [7] and semaglutide (ClinicalTrials.gov, number NCT02970942) [8], both of which have completed phase II trials, meeting their primary endpoint of NASH resolution without worsening fibrosis
Body weight reductions with oral semaglutide 14 mg and flexibly dosed varied slightly across background medication subgroups within each trial, but with no significant treatment interactions by background medication (Fig
Blood in urine : Hematuria always requires investigation to exclude infection, kidney stones, or more serious urological conditions